October 6, 2009
Tetraphase Pharmaceuticals Completes Series B Financing to Support the Advancement of Novel Antibiotic Drug Candidates

September 10, 2009
Tetraphase Presents Study Results for Novel Classes of Antibiotics from its Breakthrough Synthetic Chemistry Platform at ICAAC 2009

August 6, 2008
Tetraphase Pharmaceuticals Completes Series A Financing to Support the Advancement of Breakthrough Synthetic Chemistry Platform Raises $15M to close second tranche of $25M Financing

November 24, 2006
Tetraphase Pharmaceuticals Formed to Advance Breakthrough, Harvard-Developed Synthesis Technology for New Antibiotics to Treat Drug-Resistant Bacterial Infections